Please login to the form below

Not currently logged in
Email:
Password:

Cancer Research

This page shows the latest Cancer Research news and features for those working in and with pharma, biotech and healthcare.

Cancer Research UK among partners in new international research alliance

Cancer Research UK among partners in new international research alliance

According to Cancer Research UK (CRUK), “early detection is essential to help more people beat cancer” - diagnosing cases early significantly improves survival for patients across cancer types. ... No more siloes, no more missed opportunities; let us

Latest news

  • Women living with cancer feel stigmatized, says new report Women living with cancer feel stigmatized, says new report

    This was designed with input from the Union of International Cancer Control (UICC). ... diagnosis. “We must deploy every tool we have at hand to increase women's awareness of cancer symptoms.

  • IQVIA and partners set up cancer ‘data hub’ to speed up research IQVIA and partners set up cancer ‘data hub’ to speed up research

    The announcement of the research centre comes at a time where cancer survival rates, despite increasing in rectal and colon cancer, are trailing behind other high-income countries across the world. ... The study showed that the UK performed worse than

  • Boehringer bolsters KRAS push with $720m Lupin deal Boehringer bolsters KRAS push with $720m Lupin deal

    We believe this collaboration will significantly strengthen our KRAS programme,” said Boehringer’s head of cancer research Norbert Kraut. ... For Lupin, Boehringer is the second big biopharma partner for its pipeline of novel cancer drugs.

  • Scancell preps phase 2 challenge for melanoma vaccine Scancell preps phase 2 challenge for melanoma vaccine

    Unlike other cancer vaccine technologies ImmunoBodies can target dendritic cells, which means they can generate a broader immune response to tumours, according to Scancell. ... of SCIB2, its second ImmunoBody partnered with Cancer Research UK.

  • GSK joins forces with Doudna’s CRISPR lab GSK joins forces with Doudna’s CRISPR lab

    The collaboration consolidates GSK’s focus on genetics, having signed a collaboration consumer genetic testing and research firm 23andMe a year ago. ... A similar long-term partnership in functional genomics was unveiled by AstraZeneca with Cancer

More from news
Approximately 21 fully matching, plus 341 partially matching documents found.

Latest Intelligence

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    Living to tell the tale. Having worked in cancer research 20 years ago, I recall there was often a feeling across the field that we had hit a brick wall and ... To advance Alzheimer’s research, I believe that there are similar lessons to learn from the

  • Building Europe’s next breakthrough biotechs Building Europe’s next breakthrough biotechs

    Its founding investors include Cambridge Innovation Capital, Babraham Research Campus through Babraham Bioscience Technologies, Roche's biotech arm Genentech, and Dr Jonathan Milner and Dr Ian Tomlinson, two of the ... life sciences campus in central

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    using a standard search engine to research health worries can do more harm than good. ... She is also a Women of Influence Mentor for Cancer Research UK and a public governor for The Christie NHS Foundation Trust in Manchester and recently took on the

  • Where next in Alzheimer’s disease R&D? Where next in Alzheimer’s disease R&D?

    The work builds on research at the University of Cambridge that discovered a molecule that reduced the production of Abeta in early-stage tests. ... Yet, as the rapid pace of progress in cancer shows, decades of unsung research into disease biology can

  • Bringing life to precision medicine Bringing life to precision medicine

    Harnessing the power of patient-derived organoids. The global cancer burden. Despite enormous investment over recent decades into research and treatment development, cancer remains one of the leading causes of death ... worldwide, with 18.1 million new

More from intelligence
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest appointments

  • F-star hires ex-BMS immuno-oncology leader

    pipeline. As we saw at the recent ASCO meeting, bispecific antibodies are leading a paradigm shift in cancer care and the potential to improve the outcome for cancer patients has never ... He is an active member of the American Society of Clinical

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Under Bahija’s leadership, MedImmune significantly boosted its pipeline, expanding from 40 to more than 130 molecules in research and development targeting cancer; respiratory, inflammation, and autoimmunity; cardiovascular, renal and metabolic;

  • José Baselga joins BMS’ board of directors José Baselga joins BMS’ board of directors

    Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and ... Association for Cancer Research.

  • Glythera strengthens its scientific advisory board and appoints CSO Glythera strengthens its scientific advisory board and appoints CSO

    Dr Lutz was previously vice president of translation research and development at ImmunoGen, where he was responsible for all early-stage ADC development programmes. ... Additionally, Dr Jon Roffey joins Glythera’s scientific advisory board (SAB) from

  • Lilly bolsters its oncology team Lilly bolsters its oncology team

    cancer programme, associate director for strategic relations for the Duke Cancer Institute among other roles. ... cancer research, especially metastatic breast cancer, where she has led programmes that resulted in numerous ground-breaking regulatory

More from appointments
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 31 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics